{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:44:27Z","timestamp":1777401867555,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.sapharm.2020.07.036","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T13:20:32Z","timestamp":1597411232000},"page":"1059-1065","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Patient factors that affect opioid use among adults with and without chronic pain"],"prefix":"10.1016","volume":"17","author":[{"given":"Didem M","family":"Bernard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Encinosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengyi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2020.07.036_bib1","series-title":"The Full Cost of the Opioid Crisis: $2.5 Trillion over Four Years","author":"Council of Economic Advisors","year":"2019"},{"issue":"50-51","key":"10.1016\/j.sapharm.2020.07.036_bib2","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in drug and opioid-Involved overdose deaths -United States, 2010\u20132015","volume":"65","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2S","key":"10.1016\/j.sapharm.2020.07.036_bib3","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.36076\/ppj.2017.s92","article-title":"Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines","volume":"20","author":"Manchikanti","year":"2017","journal-title":"Pain Physician"},{"issue":"5","key":"10.1016\/j.sapharm.2020.07.036_bib4","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/pm\/pnx203","article-title":"Opioid therapy for chronic pain: overview of the 2017 US department of veterans affairs and US department of defense clinical practice guideline","volume":"19","author":"Rosenberg","year":"2018","journal-title":"Pain Med"},{"issue":"7","key":"10.1016\/j.sapharm.2020.07.036_bib5","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/AJP.0000000000000021","article-title":"The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic non-cancer pain: the role of opioid prescription","volume":"30","author":"Edlund","year":"2014","journal-title":"Clin J Pain"},{"issue":"3","key":"10.1016\/j.sapharm.2020.07.036_bib6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3122\/jabfm.2014.03.130290","article-title":"Risk of adverse health outcomes with increasing duration and regularity of opioid therapy","volume":"27","author":"Paulozzi","year":"2014","journal-title":"J Am Board Fam Med"},{"key":"10.1016\/j.sapharm.2020.07.036_bib7","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJMsr1601307","article-title":"A proactive response to prescription opioid abuse","volume":"374","author":"Califf","year":"2016","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.sapharm.2020.07.036_bib8","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1377\/hlthaff.2018.0512","article-title":"Assessing the impact of state policies for prescription drug monitoring programs on high-risk opioid prescriptions","volume":"37","author":"Bao","year":"2018","journal-title":"Health Aff (Millwood)"},{"issue":"9","key":"10.1016\/j.sapharm.2020.07.036_bib9","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1377\/hlthaff.2019.00103","article-title":"Prescription drug monitoring program mandates: impact on opioid prescribing and related hospital use","volume":"38","author":"Wen","year":"2019","journal-title":"Health Aff (Millwood)"},{"issue":"10","key":"10.1016\/j.sapharm.2020.07.036_bib10","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1377\/hlthaff.2016.0448","article-title":"Mandatory provider review and pain clinic laws reduce the amounts of opioids prescribed and overdose death rates","volume":"35","author":"Dowell","year":"2016","journal-title":"Health Aff (Millwood)"},{"issue":"15","key":"10.1016\/j.sapharm.2020.07.036_bib11","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC Guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.sapharm.2020.07.036_bib12","doi-asserted-by":"crossref","unstructured":"Chou R, Deyo R, Devine B, et al. The effectiveness and risks of long-term opioid treatment of chronic pain [Evidence Report\/Technology Assessment No. 218]. Agency Healthc Res Qual. https:\/\/effectivehealthcare.ahrq.gov\/products\/chronic-pain-opioid-treatment\/research Sept 2014 (accessed July 1, 2020).","DOI":"10.23970\/AHRQEPCERTA218"},{"issue":"2","key":"10.1016\/j.sapharm.2020.07.036_bib13","article-title":"Trends and patterns of geographic variation in opioid prescribing practices by state, United States, 2006-2017","volume":"3","author":"Schieber","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.sapharm.2020.07.036_bib14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.7326\/M18-1243","article-title":"Opioid prescribing in the United States before and after the Centers for disease control and prevention's 2016 opioid guideline","volume":"169","author":"Bohnert","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.sapharm.2020.07.036_bib15","series-title":"Key Substance Use and Mental Health Indicators in the United States: Results from the 2018 National Survey on Drug Use and Health (HHS Publication No. PEP19-5068, NSDUH Series H-54)","author":"Substance Abuse and Mental Health Services Administration","year":"2019"},{"issue":"24","key":"10.1016\/j.sapharm.2020.07.036_bib16","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1056\/NEJMp1904190","article-title":"No shortcuts to safer opioid prescribing","volume":"380","author":"Dowell","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sapharm.2020.07.036_bib18","series-title":"The National Academies Collection: Reports Funded by National Institutes of Health. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research","year":"2011"},{"key":"10.1016\/j.sapharm.2020.07.036_bib19","first-page":"897","article-title":"Analytic models to identify patients at risk for prescription opioid abuse","volume":"15","author":"White","year":"2009","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.sapharm.2020.07.036_bib20","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.pain.2010.05.020","article-title":"Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and Medicaid insurance plans: the TROUP study","volume":"150","author":"Sullivan","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.sapharm.2020.07.036_bib21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jpain.2015.01.475","article-title":"Defining risk of prescription opioid overdose: pharmacy shopping and overlapping prescriptions among long-term opioid users in Medicaid","volume":"16","author":"Yang","year":"2015","journal-title":"J Pain"},{"key":"10.1016\/j.sapharm.2020.07.036_bib22","first-page":"208","article-title":"Understanding predictors of opioid abuse: predictive model development and validation","volume":"6","author":"Dufour","year":"2014","journal-title":"Am J Pharm Benefits"},{"key":"10.1016\/j.sapharm.2020.07.036_bib23","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/j.pain.0000000000000145","article-title":"The prevalence of problem opioid use in patients receiving chronic opioid therapy: computer-assisted review of electronic health record clinical notes","volume":"156","author":"Palmer","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.sapharm.2020.07.036_bib24","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jpain.2015.01.011","article-title":"Automated prediction of risk for problem opioid use in a primary care setting","volume":"16","author":"Hylan","year":"2015","journal-title":"J Pain"},{"key":"10.1016\/j.sapharm.2020.07.036_bib25","unstructured":"Cohen S. reportSample Design of the 1997 Medical Expenditure Panel Survey Household Component, Methodology Report 11, AHRQ Pub. No. 01-0001. 2000. Rockville (MD): Agency for Healthcare Research and Quality."},{"issue":"1","key":"10.1016\/j.sapharm.2020.07.036_bib26","first-page":"18","article-title":"Treatment of chronic pain: antidepressant, antiepileptic and antiarrhythmic drugs","volume":"5","author":"Ryder","year":"2005","journal-title":"Anaesth Crit Care Pain"},{"issue":"e2","key":"10.1016\/j.sapharm.2020.07.036_bib27","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1136\/amiajnl-2013-001856","article-title":"Using electronic health records data to identify patients with chronic pain in a primary care setting","volume":"20","author":"Tian","year":"2013","journal-title":"J Am Med Inf Assoc"},{"key":"10.1016\/j.sapharm.2020.07.036_bib28","series-title":"Average Annual Opioid Use Among Adults Treated for Conditions Associated with Chronic Pain versus Other Conditions, 2013\u20132015. Research Findings #43","author":"Bernard","year":"2019"},{"key":"10.1016\/j.sapharm.2020.07.036_bib29","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.sapharm.2016.11.005","article-title":"Behavioral, mental, and physical health characteristics and opioid medication misuse among community pharmacy patients: a latent class analysis","volume":"13","author":"Cochran","year":"2019","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.sapharm.2020.07.036_bib30","unstructured":"Evidence-based Practice Center Systematic Review Protocol. Project Title: systematic review update: noninvasive non-pharmacologic treatment for chronic pain. Agency Healthc Res Qual. https:\/\/effectivehealthcare.ahrq.gov\/products\/noninvasive-nonpharm-pain-update\/protocol."}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155174112030663X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155174112030663X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:24:01Z","timestamp":1761557041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155174112030663X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S155174112030663X"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2020.07.036","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient factors that affect opioid use among adults with and without chronic pain","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2020.07.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}